- Home
- UONE vs CLSD Comparison
UONE vs CLSD Comparison
Compare UONE & CLSD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UONE
- CLSD
- Stock Information
- Founded
- UONE 1980
- CLSD 2011
- Country
- UONE United States
- CLSD United States
- Employees
- UONE 1396
- CLSD N/A
- Industry
- UONE Broadcasting
- CLSD Biotechnology: Pharmaceutical Preparations
- Sector
- UONE Consumer Discretionary
- CLSD Health Care
- Exchange
- UONE Nasdaq
- CLSD Nasdaq
- Market Cap
- UONE 72.6M
- CLSD 59.1M
- IPO Year
- UONE N/A
- CLSD 2016
- Fundamental
- Price
- UONE $1.75
- CLSD $0.87
- Analyst Decision
- UONE
- CLSD Strong Buy
- Analyst Count
- UONE 0
- CLSD 4
- Target Price
- UONE N/A
- CLSD $4.75
- AVG Volume (30 Days)
- UONE 52.4K
- CLSD 179.1K
- Earning Date
- UONE 08-07-2025
- CLSD 08-11-2025
- Dividend Yield
- UONE N/A
- CLSD N/A
- EPS Growth
- UONE N/A
- CLSD N/A
- EPS
- UONE N/A
- CLSD N/A
- Revenue
- UONE $437,499,000.00
- CLSD $3,764,000.00
- Revenue This Year
- UONE N/A
- CLSD $60.52
- Revenue Next Year
- UONE N/A
- CLSD $88.28
- P/E Ratio
- UONE N/A
- CLSD N/A
- Revenue Growth
- UONE N/A
- CLSD N/A
- 52 Week Low
- UONE $1.23
- CLSD $0.70
- 52 Week High
- UONE $2.37
- CLSD $1.65
- Technical
- Relative Strength Index (RSI)
- UONE 61.67
- CLSD 58.96
- Support Level
- UONE $1.54
- CLSD $0.80
- Resistance Level
- UONE $1.90
- CLSD $0.88
- Average True Range (ATR)
- UONE 0.12
- CLSD 0.04
- MACD
- UONE 0.02
- CLSD 0.01
- Stochastic Oscillator
- UONE 73.43
- CLSD 84.82
About UONE Urban One Inc.
Urban One Inc is an urban oriented, multi-media company. Its business is radio broadcasting franchise that is the radio broadcasting operation that targets African-American and urban listeners. It operates through the following segments: Radio Broadcasting, Reach Media, Digital, and Cable Television. The Radio Broadcasting segment includes all the broadcasting related operations. The Reach Media segment consists of the Tom Joyner Morning Show and its related activities. The Digital segment focuses on its online business, including the operations of Interactive One. The Cable Television segment deals with TV One's operations.
About CLSD Clearside Biomedical Inc.
Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injection platform, utilizing a proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina, or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases.